GlassScriptPhysician profile
Jurswin Coffey Pieternelle
NPI 1245224591
$2,063.92
in general payments reported to CMS, 2019-2025
19 companies · $26.79 in 2025
The $26.79 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $123 · 2021: $29.77 · 2022: $1,172 · 2023: $371 · 2024: $75.04 · 2025: $26.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $1,047.99 | 2022 | |
| Hologic Sales and Service, LLC | $160.74 | 2019-2024 | Aptima, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $149.22 | 2019-2022 | |
| Ethicon US, LLC | $134.92 | 2023 | Enseal, Evarrest, Echelon; Endopath |
| Abbvie INC. | $132.77 | 2019-2023 | |
| Pacira Pharmaceuticals Incorporated | $106.39 | 2023 | Exparel |
| Allergan, INC. | $79.63 | 2019-2020 | |
| Evofem Biosciences, INC. | $38.43 | 2023-2024 | Phexxi |
| Avion Pharmaceuticals | $29.06 | 2020-2023 | Balcoltra |
| Cook Medical LLC | $26.79 | 2025 | Torcon Nb |
| Lupin INC. | $24.47 | 2019-2020 | |
| Organon LLC | $19.59 | 2023 | Nexplanon |
| Myovant Sciences INC. | $18.88 | 2022 | |
| Therapeuticsmd, INC. | $18.78 | 2019 | |
| Pfizer INC. | $17.44 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $15.76 | 2023 | Myfembree |
| Vertical Pharmaceuticals, LLC | $15.75 | 2019 | |
| Shield Therapeutics INC | $14.57 | 2024 | |
| Daiichi Sankyo INC. | $12.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jurswin Pieternelle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.